Clinical trial
S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small…
NCT00030433 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00030433 |
|---|---|
| Title | S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase II Trial Of Gemcitabine (NSC-613327) And Irinotecan (NSC-616348) In Patients With Untreated Extensive Stage Small Cell Lung Cancer (SCLC) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, irinotecan hydrochloride |
| Enrollment | 85 |
| Start date | Jan 1, 2002 |
| Primary completion | Feb 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 15, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: